Literature DB >> 16819233

Chemical fingerprinting of Shexiang Baoxin Pill and simultaneous determination of its major constituents by HPLC with evaporative light scattering detection and electrospray mass spectrometric detection.

Shi-Kai Yan1, Wei-Dong Zhang, Run-Hui Liu, Yong-Cheng Zhan.   

Abstract

High-performance Liquid Chromatography (HPLC) with evaporative light scattered detection (ELSD) and electrospray ionization mass spectrometric detection (ESI-MS) was employed to establish chemical fingerprint of Shexiang Baoxin Pill (SBP) and to simultaneously determinate its seven major constituents, including cholic acid, deoxycholic acid, ursodeoxycholic acid, chenodeoxycholic acid, cinobufagin, recibufogenin, and ginsenoside Rb1. The analysis was performed on a C18 column with water-acetonitrile gradient elution, and the investigated constituents were authenticated by comparing their retention times and mass spectra with those of reference compounds. The proposed method was applied to analyze nine SBP samples and produced data with acceptable linearity, precision, stability and accuracy. Both the chemical fingerprints and quantification data were used to evaluate the quality of various SBP products. The proposed method allows obtaining chemical fingerprint and quantification of multi-components in one run, and therefore can be readily utilized as a comprehensive quality control approach for traditional Chinese medicine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819233     DOI: 10.1248/cpb.54.1058

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  8 in total

1.  Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.

Authors:  Feifei Huang; Yang Liu; Xia Yang; Di Che; Kaifeng Qiu; Bruce D Hammock; Jingfeng Wang; Mong-Heng Wang; Jie Chen; Hui Huang
Journal:  Atherosclerosis       Date:  2017-06-07       Impact factor: 5.162

2.  Shexiang Baoxin Pill, a Traditional Chinese Herbal Formula, Rescues the Cognitive Impairments in APP/PS1 Transgenic Mice.

Authors:  Wei-Hui Hu; Shing-Hung Mak; Zhong-Yu Zheng; Ying-Jie Xia; Miranda Li Xu; Ran Duan; Tina Ting-Xia Dong; Shao-Ping Li; Chang-Sen Zhan; Xiao-Hui Shang; Karl Wah-Keung Tsim
Journal:  Front Pharmacol       Date:  2020-07-14       Impact factor: 5.810

3.  Shexiang Baoxin Pill, a Proprietary Multi-Constituent Chinese Medicine, Prevents Locomotor and Cognitive Impairment Caused by Brain Ischemia and Reperfusion Injury in Rats: A Potential Therapy for Neuropsychiatric Sequelae of Stroke.

Authors:  Zong-Shi Qin; Yu Zheng; Xi-Dan Zhou; Dong-Dong Shi; Dan Cheng; Chun Shum Shek; Chang-Sen Zhan; Zhang-Jin Zhang
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

4.  Co-administration of Shexiang Baoxin Pill and Chemotherapy Drugs Potentiated Cancer Therapy by Vascular-Promoting Strategy.

Authors:  Liu-Qing Yang; Ru-Yi Li; Xi-Yan Yang; Qian-Fei Cui; Fei-Yun Wang; Guo-Qiang Lin; Jian-Ge Zhang
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

5.  Shexiang Baoxin Pill, a Formulated Chinese Herbal Mixture, Induces Neuronal Differentiation of PC12 Cells: A Signaling Triggered by Activation of Protein Kinase A.

Authors:  Miranda Li Xu; Zhong-Yu Zheng; Ying-Jie Xia; Etta Yun-Le Liu; Stanley Ka-Ho Chan; Wei-Hui Hu; Ran Duan; Tina Ting-Xia Dong; Chang-Sen Zhan; Xiao-Hui Shang; Karl Wah-Keung Tsim
Journal:  Front Pharmacol       Date:  2019-10-09       Impact factor: 5.810

6.  Combination of Ginsenosides Rb2 and Rg3 Promotes Angiogenic Phenotype of Human Endothelial Cells via PI3K/Akt and MAPK/ERK Pathways.

Authors:  Ran Joo Choi; Siti Zuraidah Mohamad Zobir; Ben Alexander-Dann; Nitin Sharma; Marcella K L Ma; Brian Y H Lam; Giles S H Yeo; Weidong Zhang; Tai-Ping Fan; Andreas Bender
Journal:  Front Pharmacol       Date:  2021-02-10       Impact factor: 5.810

7.  Metabolomic strategy for studying the intervention and the synergistic effects of the shexiang baoxin pill for treating myocardial infarction in rats.

Authors:  Li Xiang; Peng Jiang; Shuping Wang; Yaohua Hu; Xiaojun Liu; Rongcai Yue; Weidong Zhang; Runhui Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-28       Impact factor: 2.629

8.  Beneficial effects of muscone on cardiac remodeling in a mouse model of myocardial infarction.

Authors:  Xiaoyan Wang; Haoyu Meng; Pengsheng Chen; Naiquan Yang; Xin Lu; Ze-Mu Wang; Wei Gao; Ningtian Zhou; Min Zhang; Zhihui Xu; Bo Chen; Zhengxian Tao; Liangsheng Wang; Zhijian Yang; Tiebin Zhu
Journal:  Int J Mol Med       Date:  2014-05-02       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.